PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0029896|ent disease |
| Sentences | 10 |
| PubMedID- 20119936 | Hospice utilization was more likely for cancer patients who were female; over 65 years old; currently or formerly married; with ent disease; diagnosed with breast cancer or cancer having a poorer prognosis; with distant metastasis, and longer illness duration (>2 months since diagnosis); receiving care in a teaching hospital or hospital with an inpatient-hospice unit; and receiving care in a region with greater density of inpatient-hospice beds. |
| PubMedID- 25932045 | The same team also performed a retrospective analysis of heavily pre-treated triple negative breast cancer patients with recurrent disease .thirteen patients were identified who had been treated with two or more lines of chemotherapy, 12 of whom had metastatic disease in the lungs, liver, or brain. |
| PubMedID- 24355041 | These changes have been observed in in vitro models of tamoxifen resistance and in er-positive breast cancer patients with recurrent disease following endocrine treatment 7. |
| PubMedID- 21271219 | Microrna microarray analysis was performed to compare microrna levels in bone marrow from 4 breast cancer patients with recurrent disease and 4 patients without recurrence. |
| PubMedID- 26237064 | Ongoing trials are examining whether adjuvant blockade of the rankl pathway using denosumab can prevent disease recurrence in patients with high-risk breast cancer. |
| PubMedID- 25058757 | Our current study suggests that the presence of eci at metastatic slns is not associated with recurrent disease in breast cancer. |
| PubMedID- 22249258 | These genes were able to discern two groups of patients, from a published data set of tam-treated breast cancer profiles, with significantly different disease-free survival. |
| PubMedID- 22264299 | In the evaluation report comparing tamoxifen, chemotherapy, and combination therapy, smith analyzed treatments that were suitable for different disease symptoms in patients with breast cancer > 45 years old and before menopause. |
| PubMedID- 25706943 | Certainly, tumor heterogeneity and alternative survival pathways activated during drug treatment make the treatment of breast cancer patients with recurrent disease a complex and major clinical challenge and may require combination of treatment against different targets. |
| PubMedID- 24957768 | Thus, both slex and soluble e-selectin were significantly elevated in the serum of breast cancer patients with advanced and recurrent disease . |
Page: 1